INSYS Therapeutics, Inc. (INSY) was a big mover last session, as its shares rose just nearly 22% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Feb 6, as it is now up over 61%.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
INSYS Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include SurModics, Inc. (SRDX), Stryker Corporation (SYK) and Covidien plc (COV). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment